Literature DB >> 9443453

Cortical dysplasia: an immunocytochemical study of three patients.

R Spreafico1, G Battaglia, P Arcelli, F Andermann, F Dubeau, A Palmini, A Olivier, J G Villemure, D Tampieri, G Avanzini, M Avoli.   

Abstract

Human cortical dysplastic lesions are frequently associated with severe partial epilepsies. We report an immunocytochemical investigation on cortical tissue from three surgically treated patients, 20, 38, and 14 years old, with intractable epilepsy due to cortical dysplasia. The studies were performed using antibodies recognizing cytoskeletal proteins, calcium-binding proteins, and some subunits of glutamate receptors. The specimens from the three patients displayed common features: (1) focal cytoarchitectural abnormalities with an increased number of giant pyramidal neurons through all cortical layers except layer I; (2) large, round-shaped balloon cells mainly concentrated in the deepest part of the cortex and in the white matter; (3) a decrease of calcium binding protein immunopositive gamma-aminobutyric acid (GABA)ergic neurons; and (4) abnormal baskets of parvalbumin-positive terminals around the excitatory (pyramidal and large, round-shaped) neurons. These data provide evidence that the epileptogenicity in these types of cortical dysplasia is due to an increase in excitatory neurons coupled with a decrease in GABAergic interneurons.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9443453     DOI: 10.1212/wnl.50.1.27

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  36 in total

1.  Reorganization of inhibitory synaptic circuits in rodent chronically injured epileptogenic neocortex.

Authors:  Xiaoming Jin; John R Huguenard; David A Prince
Journal:  Cereb Cortex       Date:  2010-09-20       Impact factor: 5.357

2.  Down-regulated expression of acid-sensing ion channel 1a in cortical lesions of patients with focal cortical dysplasia.

Authors:  Wei Guo; Xin Chen; Jiao-Jiang He; Yu-Jia Wei; Zheng-Le Zang; Shi-Yong Liu; Hui Yang; Chun-Qing Zhang
Journal:  J Mol Neurosci       Date:  2014-03-29       Impact factor: 3.444

Review 3.  Mechanisms of epileptogenesis in tuberous sclerosis complex and related malformations of cortical development with abnormal glioneuronal proliferation.

Authors:  Michael Wong
Journal:  Epilepsia       Date:  2007-08-28       Impact factor: 5.864

4.  REORGANIZATION OF BARREL CIRCUITS LEADS TO THALAMICALLY-EVOKED CORTICAL EPILEPTIFORM ACTIVITY.

Authors:  Qian-Quan Sun; John R Huguenard; David A Prince
Journal:  Thalamus Relat Syst       Date:  2005-12

5.  Neocortical post-traumatic epileptogenesis is associated with loss of GABAergic neurons.

Authors:  Sinziana Avramescu; Dragos A Nita; Igor Timofeev
Journal:  J Neurotrauma       Date:  2009-05       Impact factor: 5.269

6.  Increased expression of the neuronal glutamate transporter (EAAT3/EAAC1) in hippocampal and neocortical epilepsy.

Authors:  Peter B Crino; Hong Jin; Melissa D Shumate; Michael B Robinson; Douglas A Coulter; Amy R Brooks-Kayal
Journal:  Epilepsia       Date:  2002-03       Impact factor: 5.864

7.  The role of voltage dependence of the NMDA receptor in cellular and network oscillation.

Authors:  Amber L Martell; Jan-Marino Ramirez; Robert E Lasky; Jennifer E Dwyer; Michael Kohrman; Wim van Drongelen
Journal:  Eur J Neurosci       Date:  2012-07       Impact factor: 3.386

8.  Reduced inhibition in an animal model of cortical dysplasia.

Authors:  W J Zhu; S N Roper
Journal:  J Neurosci       Date:  2000-12-01       Impact factor: 6.167

9.  High frequency oscillations in intracranial EEGs mark epileptogenicity rather than lesion type.

Authors:  Julia Jacobs; Pierre Levan; Claude-Edouard Châtillon; André Olivier; François Dubeau; Jean Gotman
Journal:  Brain       Date:  2009-03-18       Impact factor: 13.501

Review 10.  Epilepsy following cortical injury: cellular and molecular mechanisms as targets for potential prophylaxis.

Authors:  David A Prince; Isabel Parada; Karina Scalise; Kevin Graber; Xiaoming Jin; Fran Shen
Journal:  Epilepsia       Date:  2009-02       Impact factor: 5.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.